<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sodium iodide I-123: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sodium iodide I-123: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Sodium iodide I-123: Drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_patient" data-topicid="17064" href="/d/html/17064.html" rel="external">see "Sodium iodide I-123: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F13177199"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Radiopharmaceutical</li></ul></div>
<div class="block doa drugH1Div" id="F13177353"><span class="drugH1">Dosing: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Manufacturer dosing recommendations based on 70 kg patient.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a242dd7a-63e5-444d-b313-c1b0fb21c573">Diagnostic imaging</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Diagnostic imaging: Oral: </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Thyroid imaging:</i> 0.4 mCi (14.8 MBq); alternatively, a range of 0.2 to 0.4 mCi (7.4 to 14.8 MBq) has been recommended (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-ACR-SPR.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-ACR-SPR.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Uptake studies:</i> 0.1 mCi (3.7 MBq). <b>Note:</b> If uptake studies are performed in conjunction with thyroid imaging, the dose administered for imaging will suffice (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-ACR-SPR.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-ACR-SPR.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="448999fa-f72b-4c5e-9863-b6b5868b011f">Thyroid cancer metastases</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Thyroid cancer metastases (evaluation/localization) (off-label) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Silberstein.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Silberstein.1'])">Ref</a></span>): Oral:</b> 0.4 to 5 mCi (14.8 to 185 MBq).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="58700c33-f958-4ec8-b904-709a0fbf0750">Thyroid imaging as an adjunct in parathyroid scintigraphy</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Thyroid imaging as an adjunct in parathyroid scintigraphy (off-label) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-ACR-SPR.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-ACR-SPR.2'])">Ref</a></span>): Oral:</b> 0.2 to 0.6 mCi (7.5 to 22 MBq).</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dora drugH1Div" id="F50992086"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doha drugH1Div" id="F50989288"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doe drugH1Div" id="F50625564"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F13177352"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d0b3b20a-bf6c-4fe3-a305-d858e3440da8">Thyroid imaging</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Thyroid imaging (off-label; (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-ACR-SPR.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-ACR-SPR.1'])">Ref</a></span>)):</b> Children and Adolescents: Oral: 0.006 mCi/kg (0.2 MBq/kg)</p>
<p style="text-indent:-2em;margin-left:4em;">Dosing range: Minimum administered activity: 0.025 mCi (0.925 MBq); Maximum administered activity: 0.4 mCi (14.8 MBq)</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block adr drugH1Div" id="F13177355"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Frequency not defined.</p>
<p style="text-indent:-2em;margin-left:2em;">Cardiovascular: Chest pain, tachycardia</p>
<p style="text-indent:-2em;margin-left:2em;">Dermatologic: Pruritus, skin rash, urticaria</p>
<p style="text-indent:-2em;margin-left:2em;">Gastrointestinal: Nausea, vomiting</p></div>
<div class="block coi drugH1Div" id="F25614711"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;"> There are no contraindications listed in the manufacturer’s labeling. </p></div>
<div class="block war drugH1Div" id="F13177260"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special handling:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Radiopharmaceutical: Use appropriate precautions for handling, disposal, and minimizing exposure to patients and healthcare personnel. Use under supervision of individuals with experience/training in the handling of radioactive materials approved by the applicable regulatory authority.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concurrent drug therapy issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Iodine/thyroid medications: Concomitant use of iodine, thyroid, or antithyroid medications may interfere with the uptake of radioiodide; medications should be discontinued for an appropriate time prior to dosing.</p></div>
<div class="block foc drugH1Div" id="F50509694"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">Capsule, Oral:</p>
<p style="text-indent:-2em;margin-left:4em;">Generic: 3.7 MBq [0.1 mCi], 7.4 MBq [0.2 mCi]</p></div>
<div class="block geq drugH1Div" id="F20452771"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block fee drugH1Div" id="F56375946"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Capsules</b> (Sodium Iodide I-123 Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">3.7 mbq (per each): $130.02</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">7.4 mbq (per each): $199.97</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F20222917"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">For oral administration. Radiopharmaceutical; use appropriate precautions for handling and disposal. Waterproof gloves should be worn at all times when handling.</p></div>
<div class="block admp drugH1Div" id="F52750081"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Oral: Radiopharmaceutical; use appropriate precautions for handling and disposal. Waterproof gloves should be worn at all times when handling.</p></div>
<div class="block use drugH1Div" id="F7734447"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Diagnostic agent: </b>Evaluation of thyroid function and/or morphology</p></div>
<div class="block off-label drugH1Div" id="F25744914"><span class="drugH1">Use: Off-Label: Adult</span><p>Thyroid cancer metastases (evaluation/localization); Thyroid imaging as an adjunct to parathyroid scintigraphy; Visualization of retrosternal thyroid tissue</p></div>
<div class="block mst drugH1Div" id="F7734444"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Other safety concerns:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Radiopharmaceutical: Use appropriate precaution for handling, disposal, and minimizing exposure to patients and healthcare personnel. Use under supervision of experienced personnel. Should be stored in original lead container or adequate radiation shield.</p></div>
</div>
</div>
<div class="block rep_considerations drugH1Div" id="F53623675"><span class="drugH1">Reproductive Considerations</span>
<p style="text-indent:0em;">The manufacturer recommends elective studies be conducted during the first few (~10) days following menses in women of reproductive potential.</p></div>
<div class="block pri drugH1Div" id="F13177307"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Animal studies have not been conducted. All radiopharmaceuticals have the potential to cause fetal harm.</p></div>
<div class="block brc drugH1Div" id="F13177309"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">The amount of sodium iodide I<sup>123</sup> excreted in breast milk is variable, relating to a number of factors including thyroid uptake and renal clearance of the radioiodide.</p>
<p style="text-indent:-2em;margin-left:2em;margin-top:0em;">If the sodium iodide I<sup>123</sup> product is free from radionuclide contaminants, interruption of breast-feeding may not be necessary. However, if the sodium iodide I<sup>123</sup> product contains radionuclide contaminants, breast-feeding should be interrupted for a time ranging from 24 hours to complete cessation depending on the level of contamination (Stabin, 2000).</p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-ACR-SPR.1">
<a name="ACR-SPR.1"></a>American College of Radiology-Society for Pediatric Radiology (ACR-SPR) Practice Parameters for the Performance of Scintigraphy and Uptake Measurements for Benign and Malignant Thyroid Disease 2014a. Available at: https://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/Thyroid_Scintigraphy.pdf. Last accessed August 16, 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ACR-SPR.2">
<a name="ACR-SPR.2"></a>American College of Radiology-Society for Pediatric Radiology (ACR-SPR) Practice Parameters for the Performance of Parathyroid Scintigraphy 2014b. Available at: https://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/Parathyroid_Scintigraphy.pdf. Last accessed August 16, 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Becker.1">
<a name="Becker.1"></a>Becker DV, Charkes ND, Hurley JR, et al, “The Society of Nuclear Medicine Procedure Guideline for Thyroid Scintigraphy,” 1999. Available at http://interactive.snm.org/docs/pg_ch05_0403.pdf. Last accessed August 16, 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Silberstein.1">
<a name="Silberstein.1"></a>Silberstein EB, Alavi A, Balon HR, et al, “The Society of Nuclear Medicine Procedure Guideline for Scintigraphy for Differentiated Papillary and Follicular Thyroid Cancer,” 2006. Available at http://interactive.snm.org/docs/Scintigraphy%20for%20Differentiated%20Thyroid%20Cancer%20V3%200%20(9-25-06).pdf. Last accessed August 16, 2017.</div>
</li>
<li>
<div class="reference">
                  Sodium Iodide I123 capsules (prescribing information). Maryland Heights, MO: Curium US LLC; December 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10809203">
<a name="10809203"></a>Stabin MG and Breitz HB, "Breast Milk Excretion of Radiopharmaceuticals: Mechanisms, Findings, and Radiation Dosimetry," <i>J Nucl Med</i>, 2000, 41(5):863-73.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-iodide-i-123-drug-information/abstract-text/10809203/pubmed" id="10809203" target="_blank">10809203</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 16778 Version 83.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
